Oncology
For years, Sara worked in a hospital, making care possible for others. Now, after being diagnosed with breast cancer, she was the one in need of care.
Explore end-to-end solutions throughout development — from portfolio optimization and regulatory strategy, to Phase I-IV clinical trials, market access planning, and more.
See solutionsWHAT WE DO
HOW WE DO IT
Utilize our expertise across therapeutic areas, combining innovative trial designs, leading clinical and regulatory expertise, global reach, and a passion for changing patient lives.
See expertiseTherapeutic Expertise
Cross-Therapeutic Expertise
Our experts help you stay at the forefront of the industry - and ahead of change.
See insightsNew Medicines, Novel Insights
Discussions on Diversity
Thinking about joining a clinical trial? Learn the drug development process, what it’s like to participate, how to find a trial, and answers to frequently asked questions.
Learn moreFor years, Sara worked in a hospital, making care possible for others. Now, after being diagnosed with breast cancer, she was the one in need of care.
It took 10 years of treatments for Anisha's IBD to enter remission. But it came back in 2019 — and just as she was about to start treatment, the pandemic hit.
Want to collaborate with us to offer clinical trials at your site? We would welcome the opportunity to discuss.
Learn moreWe are one of the largest CROs in the world, speeding life-changing medicine to market by engaging patients With Heart™. Learn about who we are, what we do, and what we believe.
About ParexelWhat can we help you find today?
More than a year since the COVID-19 outbreak began, the pharmaceutical industry has shifted its focus to vaccine development for infectious diseases while continuing its pre-pandemic efforts to develop novel innovations to address unmet needs across a broad spectrum of indications. Large and small firms alike are now directing top talent and resources, including regulatory, to those efforts.
At the same time, companies cannot afford to neglect the mature products that provide the revenues to fund R&D. One way to balance these conflicting demands is to streamline the regulatory maintenance of approved products. By honing these five competencies, companies can manage post-marketing regulatory requirements better and more efficiently.
Related Insights
Blog
3 steps for making your CRO relationships more successful
Jul 29, 2021
Playbook
The upward trend of FSP outsourcing
Sep 29, 2022
Video
FSP 2.0: Why Talent Development is the New Talent Acquisition
Oct 26, 2022
Video
Identifying the right FSP candidates on day one
Aug 9, 2021
Webinar
EU-CTR: Preparing for trial transition
Nov 30, 2023
Blog
Biosimilar Development: Are therapeutic clinical trials needed?
Nov 16, 2021
Blog
Studying multiple versions of a cellular or gene therapy product in an early-phase clinical trial
Nov 19, 2021
Blog
What's the Future of FSP?
Jan 6, 2022
Video
Creating EU-CTR compliant and patient-friendly lay language summaries (LLS)
Jan 26, 2022
Video
On-demand webinar: An expert guide to EU-CTR
Mar 10, 2022
Article
New endpoints for early-stage cancer are gaining regulatory traction
Jan 28, 2022
Video
Part 2: Risk-based Quality Management Video (RBQM) Series
Nov 11, 2021